Cargando…
CD133 Targeted PVP/PMMA Microparticle Incorporating Levamisole for the Treatment of Ovarian Cancer
Levamisole (LEVA) is used to treat worm infections, but it can also inhibit cancer cell growth by inhibiting the aldehyde dehydrogenase pathway. Therefore, here, we developed a drug carrier targeting CD133, a biomarker overexpressed in ovarian cancer cells. The particle structure and cytotoxicity of...
Autores principales: | Wang, Yu-Chi, Bai, Meng-Yi, Yeh, Ying-Ting, Tang, Sung-Ling, Yu, Mu-Hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077634/ https://www.ncbi.nlm.nih.gov/pubmed/32093199 http://dx.doi.org/10.3390/polym12020479 |
Ejemplares similares
-
The Coordination and Luminescence of the Eu(III) Complexes with the Polymers (PMMA, PVP)
por: Zhao, Weican, et al.
Publicado: (2018) -
Plate-like Alginate Microparticles with Disulfiram–SPIO–Coencapsulation: An In Vivo Study for Combined Therapy on Ovarian Cancer
por: Bai, Meng-Yi, et al.
Publicado: (2021) -
CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009) -
Incorporation of CNF with Different Charge Property into PVP Hydrogel and Its Characteristics
por: Im, Wanhee, et al.
Publicado: (2021) -
Carbon nanotube incorporation in PMMA to prevent microbial adhesion
por: Kim, Kyoung-Im, et al.
Publicado: (2019)